Log in to save to my catalogue

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial...

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7581615

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy

About this item

Full title

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Strahlentherapie und Onkologie, 2020-11, Vol.196 (11), p.1006-1017

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
To assess the outcome of prostate cancer (PCa) patients diagnosed with oligorecurrent disease and treated with a first and a second PSMA (prostate-specific membrane antigen ligand) PET(positron-emission tomography)-directed radiotherapy (RT).
Patients and methods
Thirty-two patients with oligorecurrent relapse after curative therap...

Alternative Titles

Full title

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7581615

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7581615

Other Identifiers

ISSN

0179-7158

E-ISSN

1439-099X

DOI

10.1007/s00066-020-01629-5

How to access this item